Opioid Analgesics Association with Serotonin Syndrome in Patients Taking Antidepressant Medications

Subject areas

This course counts toward the state boards and subject areas below.

Disclosure statements

Completion Requirements: To receive continuing education credit commensurate with the credit awarded for this on-line activity, the participant must:

• View all modules and cases studies.
• Participate and pass all Self-Checks and Post Test(s).
• Complete and submit the on-line evaluation.

Certificates of Completion: will be available to print immediately upon finishing the completion requirements. You are encouraged to print and save your certificate for your portfolio as required by your licensing body. Interdisciplinary accredited activities, activities having multiple accreditors, will be listed individually on the Certificate of Completion.

Non-Endorsement of Products: echelon®, as an accredited provider, has demonstrated proficient experience and viable resources to provide for valid and reliable evaluation of CE activities. The accuracy of the facts and opinions contained in this activity are the responsibility of the author(s) and do not necessarily reflect those of echelon® or its sponsors. Practitioners should consult primary resources, state regulations, and their healthcare facility policies and procedures for specific application of said content to their local situation. echelon® does not imply that there is real or implied endorsement of any product, service, or company neither referred to in this activity nor of any company subsidizing costs related to this activity. All information contained in this activity is for educational purposes only.

Electronic Record Retention: All activity records are kept on file for a minimum of six (6) years.

Relevant Financial Relationships: echelon® also chooses full disclosure with each activity to report any relevant financial relationship affiliation or support in conjunction with the planning or development of any activity.

*There are no relevant financial relationships with ineligible companies for those involved with the ability to control the content of this activity.